Procter & Gamble Health Ltd EPS

Procter & Gamble Health Ltd EPS

Image

Procter & Gamble Health Ltd

NSE: PGHL

EPS

₹ 184.83

Last updated on: Feb 06, 2026

Key Highlights

  • The Earning per Share of Procter & Gamble Health Ltd is ₹ 184.83 as of 06 Feb 26 .
  • The earning per share of Procter & Gamble Health Ltd changed from ₹ 28 to ₹ 53.34 over 6 quarters. This represents a CAGR of 53.67% .

Historical Earning per Share of Procter & Gamble Health Ltd

No data available

* All values are in

Company Fundamentals for Procter & Gamble Health Ltd

Market Cap

8,621 Cr

EPS

184.8

P/E Ratio (TTM)

28.1

P/B Ratio (TTM)

13.9

Day’s High

5235.0

Day’s Low

5170.0

DTE

0.0

ROE

49.5

52 Week High

6700.0

52 Week Low

4916.0

ROCE

65.2

Market Price of Procter & Gamble Health Ltd

1M

1Y

3Y

5Y

Monitoring Procter & Gamble Health Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Feb 20265193.75
05 Feb 20265258.9
04 Feb 20265246.95
03 Feb 20265262.95
02 Feb 20265220.25
01 Feb 20265301.45
30 Jan 20265300.1
29 Jan 20265344.05
28 Jan 20265367.75
27 Jan 20265415.15

SWOT Analysis Of Procter & Gamble Health Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Procter & Gamble Health Ltd

Asset Value vs Market Value of Procter & Gamble Health Ltd

Market Value

8,621

Asset Value

Value addition

14.4 X

561

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Procter & Gamble Health Ltd8621
Sun Pharmaceutical Industries Ltd406615
Divis Laboratories Ltd159943
Torrent Pharmaceuticals Ltd133336
Cipla Ltd107499
Dr Reddys Laboratories Ltd103590

Historical Market Cap of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical Revenue of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical EBITDA of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical Net Profit of Procter & Gamble Health Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Procter & Gamble Health Ltd News Hub

P&G Health slides as Q4 PAT drops 44% YoY to Rs 17 cr

Revenue from operations slipped 5.74% year on year to Rs 283.88 crore during the quarter, owing to c

Read more

22 Aug 24

Board of Procter & Gamble Health recommends final dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meeting held on

Read more

21 Aug 24

Procter & Gamble Health to pay final dividend

Procter & Gamble Health announced that final dividend of Rs 60 per share for FY 2024 will be paid by

Read more

21 Aug 24

Broader market outperforms; European mkt opens higher

The headline equity indices traded with decent gains in afternoon trade. The Nifty hovered above the

Read more

22 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Procter & Gamble Health Ltd

What is the EPS of Procter & Gamble Health Ltd stock?

The Earnings Per Share (EPS) of Procter & Gamble Health Ltd is 184.83. An EPS is the amount of net income attributed to each share of a common stock.

How is Procter & Gamble Health Ltd EPS calculated?

The EPS of Procter & Gamble Health Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Procter & Gamble Health Ltd report its EPS?

Procter & Gamble Health Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Procter & Gamble Health Ltd EPS?

Factors that influence the EPS of Procter & Gamble Health Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Procter & Gamble Health Ltd EPS growth indicate future performance?

Yes, consistent growth in Procter & Gamble Health Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions